Monitoring of Cerebral Blood Flow in Patients on Extracorporeal Membrane Oxygenation

RecruitingOBSERVATIONAL
Enrollment

15

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

June 15, 2025

Study Completion Date

August 15, 2025

Conditions
Extracorporeal Membrane Oxygenation ComplicationCerebral Circulatory Failure
Interventions
DEVICE

VV-ECMO

VV-ECMO is indicated in case of severe respiratory failure refractory to other therapies. Indications for VV-ECMO include severe pneumonia, acute respiratory distress syndrome (ARDS) (a.o. due to COVID-19) or near-drowning. ECMO is considered a 'last resort' therapy, in which other maneuvers - such as prone positioning and neuromuscular blockage - have shown to be insufficient. Patients are generally receiving invasive mechanical ventilation and are almost always unconscious, since due to the severe respiratory failure, high doses of sedatives and neuromuscular blockage are often applied to prevent further ventilator-induced damage. After the decision for VV-ECMO is made, the patient is directly cannulated in the ICU or OR following standard protocols.

Trial Locations (1)

1105

RECRUITING

Amsterdam UMC, Amsterdam-Zuidoost

All Listed Sponsors
lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER